Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • LTR Pharma doses first patient with Erectile Dysfunction nasal spray
    • News

    LTR Pharma doses first patient with Erectile Dysfunction nasal spray

    In their attempt to provide men with alternative treatments for Erectile Dysfunction (ED), LTR Pharma (ASX: LTP) has commenced dosing its first cohort of human patients with their SPONTAN nasal spray.  Erectile Dysfunction affects millions of men globally, hampering individuals’ ability to achieve or maintain an erection suitable for sexual intercourse, leading to relationship strains

    Read More
    Public
  • XJO to open flat  after US markets give up much of their overnight gains
    • Market Update

    XJO to open flat after US markets give up much of their overnight gains

    The XJO is expected to open flat this morning despite a rally in the U.S overnight. Their futures are flat. Yesterday we were also flat as we grinded along resistance near 7,700. Our market continues to trade in a fashion where we get one or two days of volatility, which is immediately met with meek

    Read More
    Public
  • Energy management is propelling the smart buildings market at 25.7% CAGR by 2028
    • News

    Energy management is propelling the smart buildings market at 25.7% CAGR by 2028

    The increasing global smart building market is driven by energy efficiency and sustainability goals, internet of things (IoT) proliferation during the forecast period 2024-2028 amid rising cost for energy and resources.  According to TechSci Research report, “Global Smart Building Market – Global Industry Size, Share, Trends, Opportunity, and Forecast 2018-2028, The Global Smart Building Market is in the

    Read More
    Public
  • Vitura’s Cortexa becomes first Aus company to supply ecstasy and magic mushrooms under TGA’s prescriber scheme
    • News

    Vitura’s Cortexa becomes first Aus company to supply ecstasy and magic mushrooms under TGA’s prescriber scheme

    In July last year, Australia became the first country to legalise ecstasy (MDMA) and magic mushrooms (psilocybin) for mental health disorders, including PTSD and depression. A bold move, it spurred medical businesses into action, seeking the proper approvals and getting the early advantage. At the same time, not all medical professionals were so thrilled, citing

    Read More
    Public
  • dorsaVi’s movement tracking platform can now track facial features
    • News

    dorsaVi’s movement tracking platform can now track facial features

    While facial recognition continues to fall in and out of favour with the everyday Aussie, measuring privacy concerns against functionalities, AI product developers like dorsaVi (ASX: DVL) have carried on, creating niche AI products that could be worth their salt. The Company, which develops FDA-approved wearable sensors and specialises in human movement analytics, has integrated

    Read More
    Public
  • XJO to open slightly lower after Friday’s craziness
    • Market Update

    XJO to open slightly lower after Friday’s craziness

    The XJO is expected to open flat this morning. U.S futures are also flat at this stage. The U.S pulled back on Friday night, but our market had already gone through the mill during our Friday session. We sold off for much of the day but bounced off both 7,600 key support and the 50

    Read More
    Public
  • «
  • ‹
  • 104
  • 105
  • 106
  • 107
  • 108
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.